Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:PAVM NASDAQ:PFSA NASDAQ:TNON NASDAQ:XAIR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePAVMPAVmed$7.16+0.3%$9.57$6.00▼$28.44$7.11M0.6413,417 shs24,188 shsPFSAProfusa$0.52+5.3%$0.77$0.41▼$180.00$2.16M0.471.62 million shs278,745 shsTNONTenon Medical$0.73-2.6%$0.78$0.64▼$2.48$8.47M1.2884,763 shs124,718 shsXAIRBeyond Air$0.51+3.2%$0.70$0.43▼$5.84$6.56M0.3469,371 shs251,856 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePAVMPAVmed0.00%-13.98%-27.44%-33.89%-67.35%PFSAProfusa0.00%-17.79%-59.84%+740.48%+48,999,900.00%TNONTenon Medical0.00%-1.82%+1.23%+11.76%-31.18%XAIRBeyond Air0.00%-5.33%-33.79%-56.77%-86.03%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePAVMPAVmed$7.16+0.3%$9.57$6.00▼$28.44$7.11M0.6413,417 shs24,188 shsPFSAProfusa$0.52+5.3%$0.77$0.41▼$180.00$2.16M0.471.62 million shs278,745 shsTNONTenon Medical$0.73-2.6%$0.78$0.64▼$2.48$8.47M1.2884,763 shs124,718 shsXAIRBeyond Air$0.51+3.2%$0.70$0.43▼$5.84$6.56M0.3469,371 shs251,856 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePAVMPAVmed0.00%-13.98%-27.44%-33.89%-67.35%PFSAProfusa0.00%-17.79%-59.84%+740.48%+48,999,900.00%TNONTenon Medical0.00%-1.82%+1.23%+11.76%-31.18%XAIRBeyond Air0.00%-5.33%-33.79%-56.77%-86.03%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePAVMPAVmed 2.00Hold$65.00807.82% UpsidePFSAProfusa 1.00SellN/AN/ATNONTenon Medical 2.00HoldN/AN/AXAIRBeyond Air 2.33Hold$10.001,849.32% UpsideCurrent Analyst Ratings BreakdownLatest PFSA, TNON, PAVM, and XAIR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/24/2026XAIRBeyond Air Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/21/2026PAVMPAVmed Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)4/20/2026TNONTenon Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/9/2026PAVMPAVmed Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$510.00 ➝ $65.003/27/2026PFSAProfusa Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026XAIRBeyond Air D. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.003/18/2026XAIRBeyond Air D. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.003/10/2026XAIRBeyond Air D. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.00(Data available from 5/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPAVMPAVmed$70K102.29N/AN/A($2.42) per share-2.96PFSAProfusaN/AN/AN/AN/A($21.69) per shareN/ATNONTenon Medical$3.94M2.10N/AN/A$0.18 per share4.06XAIRBeyond Air$3.70M1.83N/AN/A$3.32 per share0.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePAVMPAVmed$400K-$22.77N/AN/AN/A564.79%-242.99%-17.25%5/15/2026 (Estimated)PFSAProfusa-$35.82M-$167.67N/AN/AN/AN/AN/A-1,196.99%N/ATNONTenon Medical-$12.56M-$1.99N/AN/AN/A-318.36%-409.16%-110.06%5/12/2026 (Estimated)XAIRBeyond Air-$46.62M-$5.43N/AN/AN/A-447.75%-268.82%-98.49%6/29/2026 (Estimated)Latest PFSA, TNON, PAVM, and XAIR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2026Q1 2026PAVMPAVmed-$0.69N/AN/AN/A$0.07 millionN/A5/12/2026Q1 2026TNONTenon Medical-$0.3050N/AN/AN/A$1.30 millionN/A3/19/2026Q4 2025TNONTenon Medical-$0.36-$0.22+$0.14-$0.22$1.38 million$1.48 million2/13/2026Q3 2026XAIRBeyond Air-$0.54-$0.85-$0.31-$0.85$2.15 million$2.19 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthPAVMPAVmedN/AN/AN/AN/AN/APFSAProfusaN/AN/AN/AN/AN/ATNONTenon MedicalN/AN/AN/AN/AN/AXAIRBeyond AirN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPAVMPAVmedN/A0.170.17PFSAProfusaN/A0.170.17TNONTenon MedicalN/A2.111.78XAIRBeyond Air2.655.124.77Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPAVMPAVmed19.93%PFSAProfusa9.81%TNONTenon Medical22.74%XAIRBeyond Air31.50%Insider OwnershipCompanyInsider OwnershipPAVMPAVmed5.80%PFSAProfusa11.40%TNONTenon Medical0.33%XAIRBeyond Air17.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePAVMPAVmed901.00 million938,000OptionablePFSAProfusa24.41 million3.91 millionN/ATNONTenon Medical811.30 million11.26 millionNot OptionableXAIRBeyond Air7013.19 million10.95 millionOptionablePFSA, TNON, PAVM, and XAIR HeadlinesRecent News About These CompaniesBeyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026April 20, 2026 | globenewswire.comLucid, Beyond Air, Conagra stocks hit 52-week lows: What's behind the drag?April 16, 2026 | msn.comBeyond Air Appeals Nasdaq Notice on Listing ComplianceApril 15, 2026 | tipranks.comBeyond Air to Participate in the D. Boral Capital Global Conference 2026April 15, 2026 | globenewswire.comBeyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO)April 1, 2026 | markets.businessinsider.comBeyond Air Names Robert Goodman as New CEOApril 1, 2026 | tipranks.comBeyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEOMarch 26, 2026 | markets.businessinsider.comBeyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO TrialMarch 17, 2026 | globenewswire.comBeyond Air to Participate in the 38th Annual Roth Conference in MarchMarch 11, 2026 | markets.businessinsider.comBeyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.March 10, 2026 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA) and Beyond Air (XAIR)March 8, 2026 | theglobeandmail.comBeyond Air Inc (XAIR) Expands Focus on Nitric Oxide TherapiesMarch 4, 2026 | finance.yahoo.comHow The Narrative On Beyond Air (XAIR) Is Resetting Around LungFit PH And Delayed ApprovalFebruary 26, 2026 | finance.yahoo.comBeyond Air Inc (XAIR) Q3 2026 Earnings Call Highlights: Impressive Revenue Growth and Strategic ...February 21, 2026 | finance.yahoo.comBeyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating ...February 20, 2026 | finance.yahoo.comBeyond Air, Inc. Highlights Comprehensive Review on High-Dose Inhaled Nitric Oxide as Potential Antimicrobial Therapy for Respiratory InfectionsFebruary 20, 2026 | quiverquant.comQBeyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory InfectionsFebruary 20, 2026 | globenewswire.comBeyond Air, Inc. Q3 2026 Earnings Call SummaryFebruary 14, 2026 | finance.yahoo.comBeyond Air, Inc. (NASDAQ:XAIR) Q3 2026 earnings call transcriptFebruary 14, 2026 | msn.comBeyond Air XAIR Q3 2026 Earnings Call TranscriptFebruary 13, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePFSA, TNON, PAVM, and XAIR Company DescriptionsPAVmed NASDAQ:PAVM$7.16 +0.02 (+0.28%) Closing price 05/8/2026 03:59 PM EasternExtended Trading$7.28 +0.12 (+1.68%) As of 05/8/2026 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.Profusa NASDAQ:PFSA$0.52 +0.03 (+5.27%) Closing price 05/8/2026 04:00 PM EasternExtended Trading$0.50 -0.01 (-2.29%) As of 05/8/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.Tenon Medical NASDAQ:TNON$0.73 -0.02 (-2.59%) Closing price 05/8/2026 03:59 PM EasternExtended Trading$0.76 +0.03 (+3.60%) As of 05/8/2026 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.Beyond Air NASDAQ:XAIR$0.51 +0.02 (+3.18%) Closing price 05/8/2026 04:00 PM EasternExtended Trading$0.51 0.00 (-0.58%) As of 05/8/2026 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/04 - 05/08 SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
